# Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)

> **NCT07303322** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 372 (estimated)

## Conditions studied

- Female Pattern Hair Loss
- Female Pattern Hair Loss, Androgenic Alopecia

## Interventions

- **DRUG:** N1087
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07303322
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2028-07
- **Final completion:** 2028-08
- **Target enrollment:** 372 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07303322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07303322, "Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of N1087 in Participants With Female Pattern Hair Loss (MINORA-WOMEN)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07303322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*